Smith, Salley & Associates Medtronic PLC Transaction History

Smith, Salley & Associates

$1.48 Billion
Q3 2024

A detailed history of Smith, Salley & Associates transactions in Medtronic PLC stock. As of the latest transaction made, Smith, Salley & Associates holds 173,168 shares of MDT stock, worth $14.6 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

173,168

Previous 156,766 10.46%

Holding current value

$14.6 Million

Previous $12.3 Million 26.35%

% of portfolio

1.05%

Previous 0.91%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$76.84 - $91.03 $1.26 Million - $1.49 Million	16,402 Added 10.46%	173,168 $15.6 Million
Q2 2024 Jul 29, 2024	BUY	$78.71 - $87.02 $242,426 - $268,021	3,080 Added 2.0%	156,766 $12.3 Million
Q1 2024 May 02, 2024	SELL	$82.84 - $88.09 $2.97 Million - $3.15 Million	-35,801 Reduced 18.89%	153,686 $13.4 Million
Q4 2023 Jan 24, 2024	BUY	$69.43 - $83.43 $153,509 - $184,463	2,211 Added 1.18%	189,487 $15.6 Million
Q3 2023 Oct 27, 2023	BUY	$78.22 - $90.4 $507,334 - $586,334	6,486 Added 3.59%	187,276 $14.7 Million
Q2 2023 Aug 04, 2023	BUY	$79.47 - $91.38 $179,920 - $206,884	2,264 Added 1.27%	180,790 $15.9 Million
Q1 2023 May 03, 2023	BUY	$76.72 - $87.58 $3.28 Million - $3.75 Million	42,783 Added 31.52%	178,526 $14.4 Million
Q4 2022 Feb 03, 2023	SELL	$76.18 - $87.74 $4.07 Million - $4.68 Million	-53,385 Reduced 28.23%	135,743 $10.6 Million
Q3 2022 Nov 01, 2022	BUY	$80.75 - $95.31 $104,975 - $123,903	1,300 Added 0.69%	189,128 $15.3 Million
Q2 2022 Aug 01, 2022	BUY	$87.4 - $113.09 $728,391 - $942,492	8,334 Added 4.64%	187,828 $16.9 Million
Q1 2022 May 10, 2022	BUY	$100.58 - $112.38 $1.02 Million - $1.14 Million	10,139 Added 5.99%	179,494 $19.9 Million
Q4 2021 Feb 10, 2022	SELL	$99.53 - $127.75 $11,147 - $14,308	-112 Reduced 0.07%	169,355 $17.5 Million
Q3 2021 Nov 05, 2021	BUY	$122.75 - $135.17 $362,971 - $399,697	2,957 Added 1.78%	169,467 $21.2 Million
Q2 2021 Aug 09, 2021	BUY	$118.19 - $131.5 $524,763 - $583,860	4,440 Added 2.74%	166,510 $20.7 Million
Q1 2021 Apr 30, 2021	BUY	$111.18 - $119.74 $717,666 - $772,921	6,455 Added 4.15%	162,070 $19.1 Million
Q4 2020 Jan 28, 2021	BUY	$100.57 - $117.14 $691,821 - $805,806	6,879 Added 4.62%	155,615 $18.2 Million
Q3 2020 Nov 05, 2020	BUY	$90.13 - $108.78 $2.23 Million - $2.7 Million	24,777 Added 19.99%	148,736 $15.5 Million
Q2 2020 Aug 04, 2020	BUY	$84.11 - $103.33 $1.81 Million - $2.23 Million	21,553 Added 21.05%	123,959 $11.4 Million
Q1 2020 Apr 24, 2020	SELL	$72.92 - $121.3 $1.23 Million - $2.05 Million	-16,916 Reduced 14.18%	102,406 $9.24 Million
Q4 2019 Jan 27, 2020	SELL	$104.49 - $114.54 $42,527 - $46,617	-407 Reduced 0.34%	119,322 $13.5 Million
Q3 2019 Oct 30, 2019	BUY	$98.02 - $111.18 $503,528 - $571,131	5,137 Added 4.48%	119,729 $13 Million
Q2 2019 Jul 12, 2019	BUY	$84.15 - $99.38 $301,341 - $355,879	3,581 Added 3.23%	114,592 $11.2 Million
Q1 2019 May 03, 2019	BUY	$82.45 - $93.79 $2.23 Million - $2.53 Million	27,023 Added 32.17%	111,011 $10.1 Million
Q4 2018 Feb 05, 2019	BUY	$85.8 - $99.49 $6.75 Million - $7.82 Million	78,616 Added 1463.44%	83,988 $7.64 Million
Q3 2018 Nov 06, 2018	BUY	$85.91 - $99.17 $9,364 - $10,809	109 Added 2.07%	5,372 $528,000
Q2 2018 Aug 10, 2018	BUY	$77.48 - $87.83 $3,099 - $3,513	40 Added 0.77%	5,263 $451,000
Q1 2018 May 09, 2018	SELL	$76.55 - $87.26 $21,280 - $24,258	-278 Reduced 5.05%	5,223 $419,000
Q4 2017 Feb 12, 2018	SELL	$76.93 - $83.5 $9,231 - $10,020	-120 Reduced 2.13%	5,501 $444,000
Q3 2017 Nov 02, 2017	BUY	$77.71 - $84.6 $436,807 - $475,536	5,621	5,621 $437,000

Others Institutions Holding MDT

# of Institutions

2,283

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $112B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.

Account

Smith, Salley & Associates Medtronic PLC Transaction History